| Elisabeth G Richard, MD | |
|
10753 Falls Rd, Suite 355, Pavilion Ii, Lutherville, MD 21093-4535 | |
| (410) 847-3700 | |
| Not Available |
| Full Name | Elisabeth G Richard |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 23 Years |
| Location | 10753 Falls Rd, Lutherville, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932154093 | NPI | - | NPPES |
| 408272900 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | D62684 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johns Hopkins Hospital, The | Baltimore, MD | Hospital |
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
Joseph C. Blader, Ph.D., Assistant Professor, Department of Psychiatry & Behavioral Science at Stony Brook University School of Medicine, and colleagues, found that almost half of children with attention-deficit/hyperactivity disorder whose aggressive behaviors had not been effectively controlled during routine outpatient care could achieve near absence of aggressive, explosive behavior when implementing "first-line" stimulant treatments for ADHD tailored to individual needs, along with behavioral therapy.
Neuromodulators have joined together in the Neuromodulation Appropriateness Consensus Committee (NACC) to provide the first coordinated set of recommendations about patient selection and appropriateness for implantation of "digital drugs" to manage chronic pain.
The experimental drug ibrutinib (PCI-32765) shows great promise for the treatment of elderly patients with chronic lymphocytic leukemia (CLL), according to interim findings from a clinical trial.
The Centers for Disease Control and Prevention has awarded Wayne State University's School of Social Work a three-year, $1,049,223 grant for researching the factors that facilitate and discourage intimate partner violence (IPV) perpetration among middle school and high school youth.
The controversy over recent breast cancer screening guidelines offers an opportunity to engage individual patients in an informed discussion of the importance of evidence-based clinical efficacy assessments in contributing to better care decisions, Donna Sweet, MD, MACP today told the Subcommittee on Health of the House Energy and Commerce Committee. Dr. Sweet testified at a hearing, Breast Cancer Screening Recommendations, on behalf of the American College of Physicians (ACP).
› Verified 5 days ago
| Entity Name | Elisabeth G Richard Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851779730 PECOS PAC ID: 6305159427 Enrollment ID: O20150720000496 |
News Archive
Joseph C. Blader, Ph.D., Assistant Professor, Department of Psychiatry & Behavioral Science at Stony Brook University School of Medicine, and colleagues, found that almost half of children with attention-deficit/hyperactivity disorder whose aggressive behaviors had not been effectively controlled during routine outpatient care could achieve near absence of aggressive, explosive behavior when implementing "first-line" stimulant treatments for ADHD tailored to individual needs, along with behavioral therapy.
Neuromodulators have joined together in the Neuromodulation Appropriateness Consensus Committee (NACC) to provide the first coordinated set of recommendations about patient selection and appropriateness for implantation of "digital drugs" to manage chronic pain.
The experimental drug ibrutinib (PCI-32765) shows great promise for the treatment of elderly patients with chronic lymphocytic leukemia (CLL), according to interim findings from a clinical trial.
The Centers for Disease Control and Prevention has awarded Wayne State University's School of Social Work a three-year, $1,049,223 grant for researching the factors that facilitate and discourage intimate partner violence (IPV) perpetration among middle school and high school youth.
The controversy over recent breast cancer screening guidelines offers an opportunity to engage individual patients in an informed discussion of the importance of evidence-based clinical efficacy assessments in contributing to better care decisions, Donna Sweet, MD, MACP today told the Subcommittee on Health of the House Energy and Commerce Committee. Dr. Sweet testified at a hearing, Breast Cancer Screening Recommendations, on behalf of the American College of Physicians (ACP).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elisabeth G Richard, MD 10753 Falls Rd, Suite 355, Pavilion Ii, Lutherville, MD 21093-4535 Ph: (410) 847-3700 | Elisabeth G Richard, MD 10753 Falls Rd, Suite 355, Pavilion Ii, Lutherville, MD 21093-4535 Ph: (410) 847-3700 |
News Archive
Joseph C. Blader, Ph.D., Assistant Professor, Department of Psychiatry & Behavioral Science at Stony Brook University School of Medicine, and colleagues, found that almost half of children with attention-deficit/hyperactivity disorder whose aggressive behaviors had not been effectively controlled during routine outpatient care could achieve near absence of aggressive, explosive behavior when implementing "first-line" stimulant treatments for ADHD tailored to individual needs, along with behavioral therapy.
Neuromodulators have joined together in the Neuromodulation Appropriateness Consensus Committee (NACC) to provide the first coordinated set of recommendations about patient selection and appropriateness for implantation of "digital drugs" to manage chronic pain.
The experimental drug ibrutinib (PCI-32765) shows great promise for the treatment of elderly patients with chronic lymphocytic leukemia (CLL), according to interim findings from a clinical trial.
The Centers for Disease Control and Prevention has awarded Wayne State University's School of Social Work a three-year, $1,049,223 grant for researching the factors that facilitate and discourage intimate partner violence (IPV) perpetration among middle school and high school youth.
The controversy over recent breast cancer screening guidelines offers an opportunity to engage individual patients in an informed discussion of the importance of evidence-based clinical efficacy assessments in contributing to better care decisions, Donna Sweet, MD, MACP today told the Subcommittee on Health of the House Energy and Commerce Committee. Dr. Sweet testified at a hearing, Breast Cancer Screening Recommendations, on behalf of the American College of Physicians (ACP).
› Verified 5 days ago
Samantha Faye Vincent, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1447 York Rd, Suite 301, Lutherville, MD 21093 Phone: 410-252-9090 Fax: 410-494-7064 | |
Linda C Wang, MD JD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1205 York Rd Ste 39a, Lutherville, MD 21093 Phone: 443-288-1870 Fax: 443-288-6639 | |
Amie Gupta Sessa, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1447 York Rd, Suite 301, Lutherville, MD 21093 Phone: 410-252-9090 | |
Dr. Zain Ulabedin Syed, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1447 York Rd, Suite 301, Lutherville, MD 21093 Phone: 410-252-9090 Fax: 410-494-7064 | |
Laura Anzaldi, Dermatology Medicare: Medicare Enrolled Practice Location: 1407 York Rd Ste 100a, Lutherville, MD 21093 Phone: 410-955-5000 | |
Dr. Bruce Edmund Beacham, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1205 York Rd, Ste 20, Lutherville, MD 21093 Phone: 410-583-2328 Fax: 410-583-2479 | |
Dr. Bonnie Epstein, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2360 W Joppa Rd, Suite 208, Lutherville, MD 21093 Phone: 410-823-0350 Fax: 410-823-6798 |